Chapman Investment Management LLC Boosts Stock Holdings in Intuitive Surgical, Inc. $ISRG

Chapman Investment Management LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.5% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,676 shares of the medical equipment provider’s stock after buying an additional 164 shares during the period. Intuitive Surgical accounts for approximately 1.0% of Chapman Investment Management LLC’s portfolio, making the stock its 21st largest holding. Chapman Investment Management LLC’s holdings in Intuitive Surgical were worth $1,454,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of ISRG. Vanguard Group Inc. lifted its holdings in shares of Intuitive Surgical by 1.4% during the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock valued at $16,178,258,000 after purchasing an additional 453,335 shares during the last quarter. Invesco Ltd. raised its stake in Intuitive Surgical by 1.7% during the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock valued at $2,090,027,000 after buying an additional 71,794 shares during the last quarter. Northern Trust Corp raised its stake in Intuitive Surgical by 0.3% during the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock valued at $1,798,465,000 after buying an additional 11,988 shares during the last quarter. Wellington Management Group LLP grew its position in shares of Intuitive Surgical by 15.0% during the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock valued at $1,732,975,000 after acquiring an additional 457,080 shares during the period. Finally, Nuveen LLC bought a new stake in shares of Intuitive Surgical during the 1st quarter valued at $1,715,899,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Up 1.9%

Shares of ISRG stock opened at $544.21 on Tuesday. The stock has a market cap of $195.09 billion, a price-to-earnings ratio of 71.99, a price-to-earnings-growth ratio of 4.94 and a beta of 1.61. The firm’s 50 day moving average price is $465.84 and its two-hundred day moving average price is $499.16. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter last year, the company earned $1.84 EPS. Intuitive Surgical’s quarterly revenue was up 22.9% on a year-over-year basis. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other news, CEO David J. Rosa sold 24,500 shares of the company’s stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $547.55, for a total value of $13,414,975.00. Following the sale, the chief executive officer owned 234,256 shares of the company’s stock, valued at approximately $128,266,872.80. This represents a 9.47% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Gary S. Guthart sold 2,800 shares of the company’s stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $546.27, for a total transaction of $1,529,556.00. Following the transaction, the insider owned 17,120 shares in the company, valued at approximately $9,352,142.40. The trade was a 14.06% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 96,011 shares of company stock worth $50,309,042. 0.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on ISRG shares. Erste Group Bank reaffirmed a “hold” rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Argus raised their price target on shares of Intuitive Surgical from $600.00 to $630.00 in a report on Monday, October 27th. Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Sunday, October 26th. Rothschild & Co Redburn boosted their price target on shares of Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Finally, Daiwa Capital Markets upped their price objective on shares of Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a report on Friday, October 24th. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $608.92.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.